nodes	percent_of_prediction	percent_of_DWPC	metapath
Testosterone Propionate—Clotting—Temozolomide—malignant glioma	0.0225	0.0655	CcSEcCtD
Testosterone Propionate—COMT—telencephalic ventricle—malignant glioma	0.0204	0.287	CbGeAlD
Testosterone Propionate—Personality disorder—Carmustine—malignant glioma	0.0192	0.056	CcSEcCtD
Testosterone Propionate—Coagulopathy—Temozolomide—malignant glioma	0.0103	0.0301	CcSEcCtD
Testosterone Propionate—Gamma-glutamyltransferase increased—Temozolomide—malignant glioma	0.00976	0.0284	CcSEcCtD
Testosterone Propionate—Endocrine disorder—Temozolomide—malignant glioma	0.00969	0.0282	CcSEcCtD
Testosterone Propionate—Breast pain—Temozolomide—malignant glioma	0.0092	0.0268	CcSEcCtD
Testosterone Propionate—Neoplasm—Carmustine—malignant glioma	0.00751	0.0219	CcSEcCtD
Testosterone Propionate—Gynaecomastia—Carmustine—malignant glioma	0.00743	0.0217	CcSEcCtD
Testosterone Propionate—Neoplasm—Temozolomide—malignant glioma	0.00726	0.0212	CcSEcCtD
Testosterone Propionate—Gastrointestinal haemorrhage—Carmustine—malignant glioma	0.00603	0.0176	CcSEcCtD
Testosterone Propionate—Liver function test abnormal—Carmustine—malignant glioma	0.00557	0.0162	CcSEcCtD
Testosterone Propionate—COMT—brainstem—malignant glioma	0.00552	0.0775	CbGeAlD
Testosterone Propionate—Breast disorder—Temozolomide—malignant glioma	0.00527	0.0154	CcSEcCtD
Testosterone Propionate—CYP17A1—medulla oblongata—malignant glioma	0.00527	0.0739	CbGeAlD
Testosterone Propionate—COMT—telencephalon—malignant glioma	0.0049	0.0688	CbGeAlD
Testosterone Propionate—Dysuria—Temozolomide—malignant glioma	0.00471	0.0137	CcSEcCtD
Testosterone Propionate—Erectile dysfunction—Temozolomide—malignant glioma	0.00464	0.0135	CcSEcCtD
Testosterone Propionate—Weight increased—Temozolomide—malignant glioma	0.00458	0.0134	CcSEcCtD
Testosterone Propionate—Hepatobiliary disease—Temozolomide—malignant glioma	0.00425	0.0124	CcSEcCtD
Testosterone Propionate—Haemoglobin—Carmustine—malignant glioma	0.00419	0.0122	CcSEcCtD
Testosterone Propionate—Haemorrhage—Carmustine—malignant glioma	0.00417	0.0122	CcSEcCtD
Testosterone Propionate—AR—Regulation of nuclear SMAD2/3 signaling—RUNX3—malignant glioma	0.00412	0.00711	CbGpPWpGaD
Testosterone Propionate—Connective tissue disorder—Carmustine—malignant glioma	0.0041	0.0119	CcSEcCtD
Testosterone Propionate—Haemoglobin—Temozolomide—malignant glioma	0.00405	0.0118	CcSEcCtD
Testosterone Propionate—Haemorrhage—Temozolomide—malignant glioma	0.00403	0.0118	CcSEcCtD
Testosterone Propionate—Urinary tract disorder—Temozolomide—malignant glioma	0.00398	0.0116	CcSEcCtD
Testosterone Propionate—Connective tissue disorder—Temozolomide—malignant glioma	0.00396	0.0115	CcSEcCtD
Testosterone Propionate—Urethral disorder—Temozolomide—malignant glioma	0.00395	0.0115	CcSEcCtD
Testosterone Propionate—UGT1A1—Aryl Hydrocarbon Receptor Pathway—IL12B—malignant glioma	0.00389	0.00671	CbGpPWpGaD
Testosterone Propionate—COMT—medulla oblongata—malignant glioma	0.00385	0.0541	CbGeAlD
Testosterone Propionate—UGT1A1—NRF2 pathway—FTH1—malignant glioma	0.00381	0.00658	CbGpPWpGaD
Testosterone Propionate—CYP17A1—central nervous system—malignant glioma	0.00381	0.0535	CbGeAlD
Testosterone Propionate—COMT—Biological oxidations—CYP2B6—malignant glioma	0.0037	0.00638	CbGpPWpGaD
Testosterone Propionate—AR—FOXA1 transcription factor network—SOD1—malignant glioma	0.00369	0.00638	CbGpPWpGaD
Testosterone Propionate—Alopecia—Carmustine—malignant glioma	0.00369	0.0107	CcSEcCtD
Testosterone Propionate—Angiopathy—Temozolomide—malignant glioma	0.00366	0.0107	CcSEcCtD
Testosterone Propionate—Mental disorder—Carmustine—malignant glioma	0.00366	0.0107	CcSEcCtD
Testosterone Propionate—COMT—Metapathway biotransformation—CYP2B6—malignant glioma	0.00365	0.0063	CbGpPWpGaD
Testosterone Propionate—Immune system disorder—Temozolomide—malignant glioma	0.00364	0.0106	CcSEcCtD
Testosterone Propionate—Mediastinal disorder—Temozolomide—malignant glioma	0.00363	0.0106	CcSEcCtD
Testosterone Propionate—Malnutrition—Carmustine—malignant glioma	0.00363	0.0106	CcSEcCtD
Testosterone Propionate—AR—telencephalon—malignant glioma	0.00359	0.0504	CbGeAlD
Testosterone Propionate—Alopecia—Temozolomide—malignant glioma	0.00356	0.0104	CcSEcCtD
Testosterone Propionate—CYP17A1—Biological oxidations—CYP2B6—malignant glioma	0.00354	0.00611	CbGpPWpGaD
Testosterone Propionate—Mental disorder—Temozolomide—malignant glioma	0.00353	0.0103	CcSEcCtD
Testosterone Propionate—COMT—midbrain—malignant glioma	0.00352	0.0494	CbGeAlD
Testosterone Propionate—Malnutrition—Temozolomide—malignant glioma	0.00351	0.0102	CcSEcCtD
Testosterone Propionate—CYP17A1—Metapathway biotransformation—CYP2B6—malignant glioma	0.00349	0.00603	CbGpPWpGaD
Testosterone Propionate—COMT—spinal cord—malignant glioma	0.00343	0.0482	CbGeAlD
Testosterone Propionate—Ill-defined disorder—Temozolomide—malignant glioma	0.00326	0.00949	CcSEcCtD
Testosterone Propionate—COMT—Biological oxidations—CYP2C18—malignant glioma	0.00321	0.00553	CbGpPWpGaD
Testosterone Propionate—Malaise—Temozolomide—malignant glioma	0.00317	0.00923	CcSEcCtD
Testosterone Propionate—AR—Notch-mediated HES/HEY network—HES1—malignant glioma	0.00316	0.00546	CbGpPWpGaD
Testosterone Propionate—COMT—Metapathway biotransformation—CYP2C18—malignant glioma	0.00316	0.00546	CbGpPWpGaD
Testosterone Propionate—AR—Notch-mediated HES/HEY network—NCOR1—malignant glioma	0.00314	0.00543	CbGpPWpGaD
Testosterone Propionate—Hypertension—Carmustine—malignant glioma	0.00314	0.00914	CcSEcCtD
Testosterone Propionate—Myalgia—Carmustine—malignant glioma	0.00309	0.00901	CcSEcCtD
Testosterone Propionate—Anxiety—Carmustine—malignant glioma	0.00308	0.00898	CcSEcCtD
Testosterone Propionate—COMT—Phase II conjugation—GSTP1—malignant glioma	0.00307	0.0053	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Biological oxidations—CYP2C18—malignant glioma	0.00307	0.0053	CbGpPWpGaD
Testosterone Propionate—Hypertension—Temozolomide—malignant glioma	0.00303	0.00883	CcSEcCtD
Testosterone Propionate—CYP17A1—Metapathway biotransformation—CYP2C18—malignant glioma	0.00303	0.00523	CbGpPWpGaD
Testosterone Propionate—CYP17A1—brain—malignant glioma	0.00302	0.0425	CbGeAlD
Testosterone Propionate—Confusional state—Carmustine—malignant glioma	0.00299	0.00871	CcSEcCtD
Testosterone Propionate—Arthralgia—Temozolomide—malignant glioma	0.00299	0.00871	CcSEcCtD
Testosterone Propionate—Myalgia—Temozolomide—malignant glioma	0.00299	0.00871	CcSEcCtD
Testosterone Propionate—Anxiety—Temozolomide—malignant glioma	0.00298	0.00868	CcSEcCtD
Testosterone Propionate—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.00297	0.00865	CcSEcCtD
Testosterone Propionate—Oedema—Carmustine—malignant glioma	0.00296	0.00864	CcSEcCtD
Testosterone Propionate—Discomfort—Temozolomide—malignant glioma	0.00295	0.0086	CcSEcCtD
Testosterone Propionate—Confusional state—Temozolomide—malignant glioma	0.00289	0.00842	CcSEcCtD
Testosterone Propionate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—YWHAE—malignant glioma	0.00288	0.00498	CbGpPWpGaD
Testosterone Propionate—Oedema—Temozolomide—malignant glioma	0.00286	0.00835	CcSEcCtD
Testosterone Propionate—Anaphylactic shock—Temozolomide—malignant glioma	0.00286	0.00835	CcSEcCtD
Testosterone Propionate—UGT1A1—Aryl Hydrocarbon Receptor Pathway—HES1—malignant glioma	0.00286	0.00493	CbGpPWpGaD
Testosterone Propionate—Nervous system disorder—Temozolomide—malignant glioma	0.00281	0.00819	CcSEcCtD
Testosterone Propionate—COMT—central nervous system—malignant glioma	0.00279	0.0391	CbGeAlD
Testosterone Propionate—Skin disorder—Temozolomide—malignant glioma	0.00278	0.00811	CcSEcCtD
Testosterone Propionate—COMT—cerebellum—malignant glioma	0.00272	0.0382	CbGeAlD
Testosterone Propionate—Musculoskeletal discomfort—Carmustine—malignant glioma	0.0027	0.00787	CcSEcCtD
Testosterone Propionate—Insomnia—Carmustine—malignant glioma	0.00268	0.00781	CcSEcCtD
Testosterone Propionate—AR—Nuclear Receptors—PPARG—malignant glioma	0.00267	0.00461	CbGpPWpGaD
Testosterone Propionate—Paraesthesia—Carmustine—malignant glioma	0.00266	0.00776	CcSEcCtD
Testosterone Propionate—UGT1A1—Phase II conjugation—GSTT1—malignant glioma	0.00265	0.00458	CbGpPWpGaD
Testosterone Propionate—AR—Notch-mediated HES/HEY network—HIF1A—malignant glioma	0.00265	0.00457	CbGpPWpGaD
Testosterone Propionate—Dyspnoea—Carmustine—malignant glioma	0.00264	0.0077	CcSEcCtD
Testosterone Propionate—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.00261	0.00761	CcSEcCtD
Testosterone Propionate—COMT—Biological oxidations—GSTT1—malignant glioma	0.00259	0.00448	CbGpPWpGaD
Testosterone Propionate—Insomnia—Temozolomide—malignant glioma	0.00259	0.00755	CcSEcCtD
Testosterone Propionate—Paraesthesia—Temozolomide—malignant glioma	0.00257	0.0075	CcSEcCtD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—STMN1—malignant glioma	0.00257	0.00444	CbGpPWpGaD
Testosterone Propionate—Gastrointestinal disorder—Carmustine—malignant glioma	0.00256	0.00746	CcSEcCtD
Testosterone Propionate—AR—Nongenotropic Androgen signaling—RAF1—malignant glioma	0.00256	0.00441	CbGpPWpGaD
Testosterone Propionate—Dyspnoea—Temozolomide—malignant glioma	0.00255	0.00744	CcSEcCtD
Testosterone Propionate—Pain—Carmustine—malignant glioma	0.00253	0.00739	CcSEcCtD
Testosterone Propionate—AR—Notch-mediated HES/HEY network—KDR—malignant glioma	0.00253	0.00437	CbGpPWpGaD
Testosterone Propionate—AR—spinal cord—malignant glioma	0.00251	0.0353	CbGeAlD
Testosterone Propionate—CYP17A1—Biological oxidations—GSTT1—malignant glioma	0.00248	0.00429	CbGpPWpGaD
Testosterone Propionate—Gastrointestinal disorder—Temozolomide—malignant glioma	0.00247	0.00721	CcSEcCtD
Testosterone Propionate—Fatigue—Temozolomide—malignant glioma	0.00247	0.0072	CcSEcCtD
Testosterone Propionate—Pain—Temozolomide—malignant glioma	0.00245	0.00714	CcSEcCtD
Testosterone Propionate—Feeling abnormal—Carmustine—malignant glioma	0.00244	0.00712	CcSEcCtD
Testosterone Propionate—AR—SIDS Susceptibility Pathways—RUNX3—malignant glioma	0.00244	0.00421	CbGpPWpGaD
Testosterone Propionate—COMT—Biological oxidations—PTGS1—malignant glioma	0.00243	0.00419	CbGpPWpGaD
Testosterone Propionate—Gastrointestinal pain—Carmustine—malignant glioma	0.00242	0.00706	CcSEcCtD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—NF1—malignant glioma	0.0024	0.00414	CbGpPWpGaD
Testosterone Propionate—Drospirenone—BCHE—malignant glioma	0.0024	0.374	CrCbGaD
Testosterone Propionate—AR—Notch-mediated HES/HEY network—NOTCH1—malignant glioma	0.00239	0.00412	CbGpPWpGaD
Testosterone Propionate—Feeling abnormal—Temozolomide—malignant glioma	0.00236	0.00688	CcSEcCtD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—PLK1—malignant glioma	0.00235	0.00406	CbGpPWpGaD
Testosterone Propionate—Abdominal pain—Carmustine—malignant glioma	0.00234	0.00683	CcSEcCtD
Testosterone Propionate—Gastrointestinal pain—Temozolomide—malignant glioma	0.00234	0.00683	CcSEcCtD
Testosterone Propionate—CYP17A1—Biological oxidations—PTGS1—malignant glioma	0.00233	0.00402	CbGpPWpGaD
Testosterone Propionate—Urticaria—Temozolomide—malignant glioma	0.00228	0.00663	CcSEcCtD
Testosterone Propionate—Abdominal pain—Temozolomide—malignant glioma	0.00226	0.0066	CcSEcCtD
Testosterone Propionate—AR—SIDS Susceptibility Pathways—MYB—malignant glioma	0.00225	0.00388	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Biological oxidations—CYP2B6—malignant glioma	0.00221	0.00382	CbGpPWpGaD
Testosterone Propionate—COMT—brain—malignant glioma	0.00221	0.0311	CbGeAlD
Testosterone Propionate—UGT1A1—Metapathway biotransformation—CYP2B6—malignant glioma	0.00218	0.00377	CbGpPWpGaD
Testosterone Propionate—Hypersensitivity—Carmustine—malignant glioma	0.00218	0.00637	CcSEcCtD
Testosterone Propionate—AR—SIDS Susceptibility Pathways—SOX2—malignant glioma	0.00217	0.00375	CbGpPWpGaD
Testosterone Propionate—AR—Regulation of nuclear SMAD2/3 signaling—CDKN2B—malignant glioma	0.00214	0.0037	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—MSH2—malignant glioma	0.00213	0.00367	CbGpPWpGaD
Testosterone Propionate—Asthenia—Carmustine—malignant glioma	0.00213	0.0062	CcSEcCtD
Testosterone Propionate—Hypersensitivity—Temozolomide—malignant glioma	0.00211	0.00615	CcSEcCtD
Testosterone Propionate—AR—Nuclear Receptor transcription pathway—PPARG—malignant glioma	0.00211	0.00364	CbGpPWpGaD
Testosterone Propionate—Asthenia—Temozolomide—malignant glioma	0.00206	0.00599	CcSEcCtD
Testosterone Propionate—AR—central nervous system—malignant glioma	0.00204	0.0286	CbGeAlD
Testosterone Propionate—AR—Regulation of nuclear SMAD2/3 signaling—NCOR1—malignant glioma	0.00203	0.00351	CbGpPWpGaD
Testosterone Propionate—Diarrhoea—Carmustine—malignant glioma	0.00203	0.00591	CcSEcCtD
Testosterone Propionate—Pruritus—Temozolomide—malignant glioma	0.00203	0.00591	CcSEcCtD
Testosterone Propionate—COMT—Transmission across Chemical Synapses—BCHE—malignant glioma	0.002	0.00346	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—PML—malignant glioma	0.00199	0.00343	CbGpPWpGaD
Testosterone Propionate—Dizziness—Carmustine—malignant glioma	0.00196	0.00571	CcSEcCtD
Testosterone Propionate—Diarrhoea—Temozolomide—malignant glioma	0.00196	0.00571	CcSEcCtD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—PLK1—malignant glioma	0.00195	0.00337	CbGpPWpGaD
Testosterone Propionate—AR—Androgen receptor signaling pathway—PTK2—malignant glioma	0.00193	0.00333	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Biological oxidations—CYP2C18—malignant glioma	0.00192	0.00332	CbGpPWpGaD
Testosterone Propionate—Dizziness—Temozolomide—malignant glioma	0.00189	0.00552	CcSEcCtD
Testosterone Propionate—UGT1A1—Metapathway biotransformation—CYP2C18—malignant glioma	0.00189	0.00327	CbGpPWpGaD
Testosterone Propionate—AR—Androgen receptor signaling pathway—NCOR1—malignant glioma	0.00189	0.00326	CbGpPWpGaD
Testosterone Propionate—Vomiting—Carmustine—malignant glioma	0.00188	0.00549	CcSEcCtD
Testosterone Propionate—COMT—Transmission across Chemical Synapses—SLC6A3—malignant glioma	0.00188	0.00325	CbGpPWpGaD
Testosterone Propionate—Rash—Carmustine—malignant glioma	0.00187	0.00545	CcSEcCtD
Testosterone Propionate—Dermatitis—Carmustine—malignant glioma	0.00187	0.00544	CcSEcCtD
Testosterone Propionate—Headache—Carmustine—malignant glioma	0.00186	0.00541	CcSEcCtD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—WT1—malignant glioma	0.00185	0.00319	CbGpPWpGaD
Testosterone Propionate—Methyltestosterone—CYP2B6—malignant glioma	0.00185	0.287	CrCbGaD
Testosterone Propionate—UGT1A1—Phase II conjugation—GSTP1—malignant glioma	0.00184	0.00318	CbGpPWpGaD
Testosterone Propionate—Vomiting—Temozolomide—malignant glioma	0.00182	0.00531	CcSEcCtD
Testosterone Propionate—COMT—Metabolism—RTEL1—malignant glioma	0.00182	0.00314	CbGpPWpGaD
Testosterone Propionate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—TERT—malignant glioma	0.00181	0.00313	CbGpPWpGaD
Testosterone Propionate—Rash—Temozolomide—malignant glioma	0.00181	0.00526	CcSEcCtD
Testosterone Propionate—Dermatitis—Temozolomide—malignant glioma	0.0018	0.00526	CcSEcCtD
Testosterone Propionate—COMT—Biological oxidations—GSTP1—malignant glioma	0.0018	0.0031	CbGpPWpGaD
Testosterone Propionate—Headache—Temozolomide—malignant glioma	0.00179	0.00523	CcSEcCtD
Testosterone Propionate—COMT—Metapathway biotransformation—GSTP1—malignant glioma	0.00177	0.00306	CbGpPWpGaD
Testosterone Propionate—Nausea—Carmustine—malignant glioma	0.00176	0.00513	CcSEcCtD
Testosterone Propionate—CYP17A1—Metabolism—RTEL1—malignant glioma	0.00174	0.003	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Biological oxidations—GSTP1—malignant glioma	0.00172	0.00297	CbGpPWpGaD
Testosterone Propionate—Nausea—Temozolomide—malignant glioma	0.0017	0.00496	CcSEcCtD
Testosterone Propionate—CYP17A1—Metapathway biotransformation—GSTP1—malignant glioma	0.0017	0.00293	CbGpPWpGaD
Testosterone Propionate—AR—SIDS Susceptibility Pathways—YWHAE—malignant glioma	0.00169	0.00292	CbGpPWpGaD
Testosterone Propionate—AR—SIDS Susceptibility Pathways—NTRK2—malignant glioma	0.00169	0.00292	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Aryl Hydrocarbon Receptor Pathway—IFNG—malignant glioma	0.00167	0.00288	CbGpPWpGaD
Testosterone Propionate—AR—Regulation of Androgen receptor activity—MDM2—malignant glioma	0.00167	0.00288	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—PML—malignant glioma	0.00165	0.00284	CbGpPWpGaD
Testosterone Propionate—AR—brain—malignant glioma	0.00162	0.0227	CbGeAlD
Testosterone Propionate—UGT1A1—Biological oxidations—GSTT1—malignant glioma	0.00155	0.00268	CbGpPWpGaD
Testosterone Propionate—AR—Coregulation of Androgen receptor activity—CDKN2A—malignant glioma	0.00154	0.00266	CbGpPWpGaD
Testosterone Propionate—AR—Androgen receptor signaling pathway—CAV1—malignant glioma	0.00154	0.00265	CbGpPWpGaD
Testosterone Propionate—COMT—Neuronal System—BCHE—malignant glioma	0.00153	0.00265	CbGpPWpGaD
Testosterone Propionate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—APC—malignant glioma	0.00153	0.00263	CbGpPWpGaD
Testosterone Propionate—UGT1A1—NRF2 pathway—SLC5A5—malignant glioma	0.00152	0.00263	CbGpPWpGaD
Testosterone Propionate—AR—Nongenotropic Androgen signaling—PIK3CA—malignant glioma	0.00152	0.00263	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—TOP2A—malignant glioma	0.00151	0.0026	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Aryl Hydrocarbon Receptor Pathway—IL1B—malignant glioma	0.00149	0.00257	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Aryl Hydrocarbon Receptor Pathway—IL2—malignant glioma	0.00148	0.00256	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Biological oxidations—PTGS1—malignant glioma	0.00146	0.00251	CbGpPWpGaD
Testosterone Propionate—UGT1A1—NRF2 pathway—SLC6A3—malignant glioma	0.00145	0.0025	CbGpPWpGaD
Testosterone Propionate—COMT—Neuronal System—SLC6A3—malignant glioma	0.00144	0.00249	CbGpPWpGaD
Testosterone Propionate—AR—SIDS Susceptibility Pathways—GJA1—malignant glioma	0.00139	0.0024	CbGpPWpGaD
Testosterone Propionate—AR—Notch-mediated HES/HEY network—STAT3—malignant glioma	0.00138	0.00239	CbGpPWpGaD
Testosterone Propionate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MMP2—malignant glioma	0.00135	0.00233	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—BRCA2—malignant glioma	0.00131	0.00227	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	0.00124	0.00215	CbGpPWpGaD
Testosterone Propionate—AR—Nongenotropic Androgen signaling—AKT1—malignant glioma	0.00124	0.00215	CbGpPWpGaD
Testosterone Propionate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CDKN2A—malignant glioma	0.00124	0.00214	CbGpPWpGaD
Testosterone Propionate—UGT1A1—NRF2 pathway—GSTP1—malignant glioma	0.00123	0.00212	CbGpPWpGaD
Testosterone Propionate—AR—SIDS Susceptibility Pathways—HES1—malignant glioma	0.00121	0.00209	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	0.0012	0.00208	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—NTRK1—malignant glioma	0.00117	0.00202	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—malignant glioma	0.00114	0.00196	CbGpPWpGaD
Testosterone Propionate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CXCL8—malignant glioma	0.00112	0.00194	CbGpPWpGaD
Testosterone Propionate—Drospirenone—PTGS2—malignant glioma	0.00111	0.172	CrCbGaD
Testosterone Propionate—AR—Androgen receptor signaling pathway—MDM2—malignant glioma	0.0011	0.0019	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—BRCA2—malignant glioma	0.00109	0.00188	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—RTEL1—malignant glioma	0.00109	0.00188	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Aryl Hydrocarbon Receptor Pathway—TNF—malignant glioma	0.00108	0.00187	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—CDKN2B—malignant glioma	0.00108	0.00186	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Biological oxidations—GSTP1—malignant glioma	0.00108	0.00186	CbGpPWpGaD
Testosterone Propionate—Testosterone—CYP2B6—malignant glioma	0.00107	0.167	CrCbGaD
Testosterone Propionate—UGT1A1—Metapathway biotransformation—GSTP1—malignant glioma	0.00106	0.00183	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—COX8A—malignant glioma	0.00104	0.0018	CbGpPWpGaD
Testosterone Propionate—COMT—Transmission across Chemical Synapses—BRAF—malignant glioma	0.00102	0.00176	CbGpPWpGaD
Testosterone Propionate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MMP9—malignant glioma	0.00102	0.00175	CbGpPWpGaD
Testosterone Propionate—AR—SIDS Susceptibility Pathways—HIF1A—malignant glioma	0.00101	0.00175	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—COX8A—malignant glioma	0.000999	0.00173	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—PDGFRA—malignant glioma	0.000981	0.00169	CbGpPWpGaD
Testosterone Propionate—UGT1A1—NRF2 pathway—PDGFB—malignant glioma	0.00097	0.00167	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—BAD—malignant glioma	0.000947	0.00164	CbGpPWpGaD
Testosterone Propionate—AR—Androgen receptor signaling pathway—PTEN—malignant glioma	0.000927	0.0016	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	0.000893	0.00154	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—ASMT—malignant glioma	0.000887	0.00153	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—FGFR1—malignant glioma	0.000876	0.00151	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—BRAF—malignant glioma	0.000862	0.00149	CbGpPWpGaD
Testosterone Propionate—COMT—Transmission across Chemical Synapses—MDM2—malignant glioma	0.000856	0.00148	CbGpPWpGaD
Testosterone Propionate—COMT—Transmission across Chemical Synapses—RAF1—malignant glioma	0.000853	0.00147	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—ASMT—malignant glioma	0.00085	0.00147	CbGpPWpGaD
Testosterone Propionate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MYC—malignant glioma	0.000839	0.00145	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—BCAN—malignant glioma	0.000834	0.00144	CbGpPWpGaD
Testosterone Propionate—AR—Regulation of nuclear SMAD2/3 signaling—MYC—malignant glioma	0.000831	0.00143	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	0.000831	0.00143	CbGpPWpGaD
Testosterone Propionate—AR—Androgen receptor signaling pathway—STAT3—malignant glioma	0.000829	0.00143	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—BCAN—malignant glioma	0.000799	0.00138	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—BAD—malignant glioma	0.000785	0.00136	CbGpPWpGaD
Testosterone Propionate—COMT—Neuronal System—BRAF—malignant glioma	0.000783	0.00135	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—APC—malignant glioma	0.00076	0.00131	CbGpPWpGaD
Testosterone Propionate—AR—Androgen receptor signaling pathway—EGFR—malignant glioma	0.000754	0.0013	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—EGF—malignant glioma	0.000752	0.0013	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—BCL2—malignant glioma	0.000733	0.00127	CbGpPWpGaD
Testosterone Propionate—AR—Coregulation of Androgen receptor activity—AKT1—malignant glioma	0.000723	0.00125	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—MDM2—malignant glioma	0.000723	0.00125	CbGpPWpGaD
Testosterone Propionate—AR—Generic Transcription Pathway—NOTCH3—malignant glioma	0.000696	0.0012	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—IDH2—malignant glioma	0.000672	0.00116	CbGpPWpGaD
Testosterone Propionate—AR—SIDS Susceptibility Pathways—CXCL8—malignant glioma	0.000658	0.00114	CbGpPWpGaD
Testosterone Propionate—COMT—Neuronal System—MDM2—malignant glioma	0.000656	0.00113	CbGpPWpGaD
Testosterone Propionate—COMT—Neuronal System—RAF1—malignant glioma	0.000654	0.00113	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—CASP3—malignant glioma	0.000647	0.00112	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—IDH2—malignant glioma	0.000644	0.00111	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—FGF2—malignant glioma	0.00064	0.0011	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—CYP2B6—malignant glioma	0.000632	0.00109	CbGpPWpGaD
Testosterone Propionate—AR—SIDS Susceptibility Pathways—IL1B—malignant glioma	0.000631	0.00109	CbGpPWpGaD
Testosterone Propionate—AR—SIDS Susceptibility Pathways—CASP3—malignant glioma	0.00063	0.00109	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—COX8A—malignant glioma	0.000625	0.00108	CbGpPWpGaD
Testosterone Propionate—AR—Generic Transcription Pathway—NOTCH2—malignant glioma	0.000624	0.00108	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—BCL2—malignant glioma	0.000608	0.00105	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—PTEN—malignant glioma	0.000608	0.00105	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	0.000607	0.00105	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—CYP2B6—malignant glioma	0.000605	0.00105	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—MDM2—malignant glioma	0.000599	0.00103	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—RAF1—malignant glioma	0.000597	0.00103	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—ERBB2—malignant glioma	0.00059	0.00102	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—IDH1—malignant glioma	0.000578	0.000998	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—PTGS2—malignant glioma	0.000577	0.000997	CbGpPWpGaD
Testosterone Propionate—AR—Regulation of nuclear SMAD2/3 signaling—AKT1—malignant glioma	0.000576	0.000995	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—SPHK1—malignant glioma	0.00056	0.000966	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—IDH1—malignant glioma	0.000554	0.000956	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—VEGFA—malignant glioma	0.000549	0.000947	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—CYP2C18—malignant glioma	0.000548	0.000946	CbGpPWpGaD
Testosterone Propionate—AR—Generic Transcription Pathway—CDKN2B—malignant glioma	0.000536	0.000926	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—SPHK1—malignant glioma	0.000536	0.000925	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—CASP3—malignant glioma	0.000536	0.000925	CbGpPWpGaD
Testosterone Propionate—AR—SIDS Susceptibility Pathways—VEGFA—malignant glioma	0.000535	0.000923	CbGpPWpGaD
Testosterone Propionate—AR—Androgen receptor signaling pathway—AKT1—malignant glioma	0.000534	0.000923	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—ASMT—malignant glioma	0.000532	0.000918	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—CYP2C18—malignant glioma	0.000525	0.000906	CbGpPWpGaD
Testosterone Propionate—AR—Generic Transcription Pathway—NCOR1—malignant glioma	0.000509	0.000878	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—MYC—malignant glioma	0.000505	0.000872	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—PTEN—malignant glioma	0.000503	0.000869	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—BCAN—malignant glioma	0.0005	0.000863	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	0.000495	0.000855	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—EGFR—malignant glioma	0.000494	0.000853	CbGpPWpGaD
Testosterone Propionate—AR—Gene Expression—DNMT3B—malignant glioma	0.000475	0.000821	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—KRAS—malignant glioma	0.000467	0.000805	CbGpPWpGaD
Testosterone Propionate—AR—Gene Expression—HIST1H3B—malignant glioma	0.000462	0.000797	CbGpPWpGaD
Testosterone Propionate—AR—SIDS Susceptibility Pathways—TNF—malignant glioma	0.000458	0.000791	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—VEGFA—malignant glioma	0.000455	0.000785	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	0.000451	0.000778	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—GSTT1—malignant glioma	0.000443	0.000765	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	0.000435	0.000751	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—GSTT1—malignant glioma	0.000425	0.000733	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—MYC—malignant glioma	0.000418	0.000722	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—PTGS1—malignant glioma	0.000415	0.000717	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—TP53—malignant glioma	0.000415	0.000716	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—EGFR—malignant glioma	0.000409	0.000706	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—IDH2—malignant glioma	0.000403	0.000696	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—PTGS1—malignant glioma	0.000398	0.000687	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	0.000396	0.000684	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—TNF—malignant glioma	0.00039	0.000673	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—KRAS—malignant glioma	0.000387	0.000667	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—BCHE—malignant glioma	0.000386	0.000667	CbGpPWpGaD
Testosterone Propionate—AR—Generic Transcription Pathway—NOTCH1—malignant glioma	0.000386	0.000667	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—SLC5A5—malignant glioma	0.000382	0.000659	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—CYP2B6—malignant glioma	0.000379	0.000654	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—BCHE—malignant glioma	0.00037	0.000639	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—SLC5A5—malignant glioma	0.000365	0.000631	CbGpPWpGaD
Testosterone Propionate—AR—Generic Transcription Pathway—PPARG—malignant glioma	0.000365	0.000629	CbGpPWpGaD
Testosterone Propionate—AR—Gene Expression—H3F3A—malignant glioma	0.000357	0.000616	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—PIK3CA—malignant glioma	0.000355	0.000613	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—AKT1—malignant glioma	0.00035	0.000604	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—IDH1—malignant glioma	0.000346	0.000598	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	0.000346	0.000596	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—TP53—malignant glioma	0.000344	0.000593	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	0.000342	0.000591	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—SPHK1—malignant glioma	0.000335	0.000579	CbGpPWpGaD
Testosterone Propionate—AR—Gene Expression—NOTCH3—malignant glioma	0.000335	0.000578	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—CYP2C18—malignant glioma	0.000328	0.000567	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—GSTP1—malignant glioma	0.000307	0.000531	CbGpPWpGaD
Testosterone Propionate—AR—Gene Expression—NOTCH2—malignant glioma	0.0003	0.000519	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—CAT—malignant glioma	0.000299	0.000516	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	0.000299	0.000515	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—GSTP1—malignant glioma	0.000294	0.000508	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—AKT1—malignant glioma	0.00029	0.000501	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—CAT—malignant glioma	0.000286	0.000494	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—NCOR1—malignant glioma	0.000282	0.000488	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—NCOR1—malignant glioma	0.00027	0.000467	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—GSTT1—malignant glioma	0.000266	0.000459	CbGpPWpGaD
Testosterone Propionate—AR—Gene Expression—CDKN2B—malignant glioma	0.000258	0.000446	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—PTGS1—malignant glioma	0.000249	0.00043	CbGpPWpGaD
Testosterone Propionate—AR—Gene Expression—NCOR1—malignant glioma	0.000245	0.000423	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—BCHE—malignant glioma	0.000231	0.000399	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—CAV1—malignant glioma	0.00023	0.000397	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—SLC5A5—malignant glioma	0.000229	0.000395	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—CAV1—malignant glioma	0.00022	0.000381	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	0.000211	0.000364	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—PIK3CG—malignant glioma	0.00021	0.000362	CbGpPWpGaD
Testosterone Propionate—AR—Generic Transcription Pathway—MYC—malignant glioma	0.000208	0.000359	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—PPARG—malignant glioma	0.000202	0.000349	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—PIK3CG—malignant glioma	0.000201	0.000347	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—PPARG—malignant glioma	0.000194	0.000335	CbGpPWpGaD
Testosterone Propionate—AR—Gene Expression—NOTCH1—malignant glioma	0.000186	0.000321	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—PIK3CD—malignant glioma	0.000184	0.000318	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—GSTP1—malignant glioma	0.000184	0.000318	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—CAT—malignant glioma	0.000179	0.000309	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—PIK3CD—malignant glioma	0.000177	0.000305	CbGpPWpGaD
Testosterone Propionate—AR—Gene Expression—PPARG—malignant glioma	0.000176	0.000303	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—NCOR1—malignant glioma	0.000169	0.000292	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—PIK3CB—malignant glioma	0.000161	0.000277	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—PTGS2—malignant glioma	0.000159	0.000275	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—PIK3CB—malignant glioma	0.000154	0.000266	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—PTGS2—malignant glioma	0.000152	0.000263	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—PTEN—malignant glioma	0.000139	0.00024	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—CAV1—malignant glioma	0.000138	0.000238	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—PTEN—malignant glioma	0.000133	0.00023	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—PIK3CG—malignant glioma	0.000126	0.000217	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—PPARG—malignant glioma	0.000121	0.000209	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—PIK3CD—malignant glioma	0.00011	0.000191	CbGpPWpGaD
Testosterone Propionate—AR—Gene Expression—MYC—malignant glioma	0.0001	0.000173	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—PIK3CA—malignant glioma	9.8e-05	0.000169	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—PIK3CB—malignant glioma	9.63e-05	0.000166	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—PTGS2—malignant glioma	9.54e-05	0.000165	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—PIK3CA—malignant glioma	9.38e-05	0.000162	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—PTEN—malignant glioma	8.32e-05	0.000144	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—AKT1—malignant glioma	8e-05	0.000138	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—AKT1—malignant glioma	7.66e-05	0.000132	CbGpPWpGaD
Testosterone Propionate—AR—Gene Expression—AKT1—malignant glioma	6.94e-05	0.00012	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—PIK3CA—malignant glioma	5.87e-05	0.000101	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—AKT1—malignant glioma	4.79e-05	8.28e-05	CbGpPWpGaD
